• Most Popular
  • Most Shared

Schering says FDA to review schizophrenia drug

Mon Nov 26, 2007 4:36am EST

NEW YORK, Nov 26 (Reuters) - Schering-Plough Corp SGP.N on Monday said the U.S. Food and Drug Administration accepted for review its new drug application for asenapine, which is used to treat schizophrenia.

Stocks  |  Regulatory News

The company said the FDA will conduct a standard review of the drug, which the company acquired last week through its purchase of Organon BioSciences.

Schering-Plough also said the drug has been used in a clinical trial program involving nearly 3,000 patients. (Reporting by Justin Grant; Editing by David Holmes)

Stocks
Regulatory News


More from Reuters

Joint Terminal Attack Controller SSgt Clinton J. Herbison, a U.S. Airman from the 817 Expeditionary Air Support Operations Squadron (EASOS) takes a break during a night mission near Honaker Miracle camp at the Pesh valley of Kunar Province August 12, 2009. Credit: REUTERS/Carlos Barria

Pictures of the Year

A look at the best photos of 2009.  Slideshow 

    PICTURES
    The Dalai Lama jokes with a nasal spray after being asked his opinion on the swine flu during a press conference after his first lecture in Lausanne, Switzerland, August 4, 2009. REUTERS/ Valentin Flauraud

    What a wacky year it's been...

    Um, what's up the Dalai Lama's nose? "Oddly Enough" editor Bob Basler rounds up the goofiest photos of the year.  Full Article 

    Oddly Enough
    A caution sign is seen next to a stock board at the Australian Securities Exchange (ASX) in Sydney September 5, 2008. REUTERS/Daniel Munoz
    Political Risk in 2010:

    Don't say we didn't warn you

    With the financial crisis (mostly) in the past, U.S. investors are eying a fresh start to the coming year. Here's a look at what speedbumps lie ahead.  Full Article 

    Global Markets